Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door? (Q38149753)

29 August 2017

title

Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door? (English)

1 reference

29 August 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24096700%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Subhankar Paul

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24096700%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

5 October 2013

1 reference

Molecular and Cellular Biochemistry

29 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24096700%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24096700%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24096700%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

45-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24096700%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic approaches to protein-misfolding diseases

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Protein misfolding and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

'Unfolding' pathways in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Molecular chaperones in cellular protein folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Role of quality control pathways in human diseases involving protein misfolding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Roles of molecular chaperones in protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Heat-shock proteins as molecular chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Unfolding the role of chaperones and chaperonins in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

The Hsp70 and Hsp60 chaperone machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Chaperonin-mediated protein folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Roles of molecular chaperones in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

A model for the cytoplasmic trafficking of signalling proteins involving the hsp90-binding immunophilins and p50cdc37.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Hsp90: chaperoning signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Hsp90: a specialized but essential protein-folding tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

New insights into the ATP-dependent Clp protease: Escherichia coli and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Small heat shock proteins, the cytoskeleton, and inclusion body formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Heat shock, stress proteins, chaperones, and proteotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Modulation of neurodegeneration by molecular chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Lysosomes, a meeting point of proteins, chaperones, and proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

HSP90 and the chaperoning of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Protein-misfolding diseases and chaperone-based therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Tau protein and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Neurodegenerative disorders of protein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Recent advances in the genetics and pathogenesis of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

alpha-synuclein promotes mitochondrial deficit and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Shattuck lecture--neurodegenerative diseases and prions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Structural clues to prion replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Folding of prion protein to its native alpha-helical conformation is under kinetic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Cellular prion protein transduces neuroprotective signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Protein aggregation and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Expression of heat shock proteins in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Chaperones increase association of tau protein with microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Therapeutic opportunities in polyglutamine disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Impaired heat shock response in cells expressing full-length polyglutamine-expanded huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Hsp70 and Hsp40 Functionally Interact with Soluble Mutant Huntingtin Oligomers in a Classic ATP-dependent Reaction Cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Molecular chaperones in the cytosol: from nascent chain to folded protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Loss of Hsp70 in Drosophila is pleiotropic, with effects on thermotolerance, recovery from heat shock and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

HSP70 interacting protein prevents the accumulation of inclusions in polyglutamine disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Pharmacological prevention of Parkinson disease in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Hsp70 Reduces alpha-Synuclein Aggregation and Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Abeta40 and Abeta42 secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Hsp70 alters tau function and aggregation in an isoform specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Heat‐shock protein 70 modulates toxic extracellular α‐synuclein oligomers and rescues trans‐synaptic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Chaperone-dependent amyloid assembly protects cells from prion toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Curing of yeast [URE3] prion by the Hsp40 cochaperone Ydj1p is mediated by Hsp70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

A chaperone pathway in protein disaggregation. Hsp26 alters the nature of protein aggregates to facilitate reactivation by Hsp104.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Polyglutamine-mediated neurodegeneration: use of chaperones as prevention strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

The effect of neuronal expression of heat shock proteins 26 and 27 on lifespan, neurodegeneration, and apoptosis in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Genetic suppression of polyglutamine toxicity in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Chaperone-supervised conversion of prion protein to its protease-resistant form

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Mechanism of prion loss after Hsp104 inactivation in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Heat shock proteins and protection of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Celastrol: Molecular targets of Thunder God Vine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Hsp70 and its molecular role in nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Design of novel Geldanamycin analogue hsp90 alpha-inhibitor in silico for breast cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1844-Y

alpha-Synuclein shares physical and functional homology with 14-3-3 proteins

21 January 2018

1 reference

12 December 2020

Current status of treatment of spinal and bulbar muscular atrophy.

1 reference

12 December 2020

Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation

1 reference

12 December 2020

Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis

1 reference

12 December 2020

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity

1 reference

12 December 2020

Hsp40 interacts directly with the native state of the yeast prion protein Ure2 and inhibits formation of amyloid-like fibrils

1 reference

12 December 2020

Small stress proteins: chaperones that act as regulators of intracellular redox state and programmed cell death

1 reference

12 December 2020

Creutzfeldt-Jakob disease cosegregates with the codon 178Asn PRNP mutation in families of European origin

1 reference

12 December 2020

Heat shock protein 90 modulates LRRK2 stability: potential implications for Parkinson's disease treatment.

1 reference

12 December 2020

Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract

1 reference

12 December 2020

17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse

1 reference

12 December 2020

In silico design of small peptide-based Hsp90 inhibitor: a novel anticancer agent.

1 reference

12 December 2020

Development of therapeutics for spinal and bulbar muscular atrophy (SBMA)

1 reference

12 December 2020

The induction of heat shock proteins as a potential strategy to treat neurodegenerative disorders.

1 reference

12 December 2020

Herbimycins D-F, ansamycin analogues from Streptomyces sp. RM-7-15

1 reference

12 December 2020

Increased expression of heat-shock protein 27 kDa in Alzheimer disease: a preliminary study

1 reference

12 December 2020

Alpha-synuclein and Parkinson's disease: selective neurodegenerative effect of alpha-synuclein fragment on dopaminergic neurons in vitro and in vivo

1 reference

12 December 2020

Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer

1 reference

12 December 2020

The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones.

1 reference

12 December 2020

Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies

1 reference

12 December 2020

10.1007/S11010-013-1844-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24096700%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 June 2020

1051017821

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24096700%20AND%20SRC:MED&resulttype=core&format=json